ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
ID: 348563Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $220K

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/348563

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-199.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering funding for the ClinGen Genomic Curation Expert Panels through a cooperative agreement aimed at enhancing the clinical applicability of genomic information. This initiative invites applications to establish Expert Panels that will focus on genes and genomic variants associated with high-priority diseases, as identified by various NIH Institutes and Centers, to systematically determine their clinical significance for diagnosis and treatment. The funding, capped at $220,000 per year for up to three years, is intended to support the development of standardized procedures for assessing the clinical relevance of genetic variants, thereby contributing to precision medicine. Interested applicants can find more information and guidelines at the NIH grants website, with a submission deadline of May 25, 2025, and inquiries directed to grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-199-Full-Announcement.html
    PAR-23-199.html
    The Department of Health and Human Services is announcing funding for ClinGen Genomic Curation Expert Panels to improve the clinical applicability of genomic information. This Notice of Funding Opportunity (NOFO) invites applications for Expert Panels focusing on genes and variants critical to high-priority diseases identified by various NIH Institutes and Centers, like NICHD, NCI, and NIMH. The goal is to establish standardized procedures for determining the clinical significance of genetic variants to support precision medicine. Eligible applicants include higher education institutions and nonprofits, with a budget cap of $220,000 per year for up to three years. Applications must adhere to NIH guidelines and include a Data Management and Sharing Plan. The review will consider significance, investigator expertise, innovative contributions, and methodological approaches in addition to the overall impact of the project. Successful applications will utilize ClinGen's resources for systematic data sharing and curation, collaborating within existing Clinical Domain Working Groups to optimize efforts without duplication. This initiative reinforces NIH's focus on enhancing genomic resources for improving health outcomes through shared expertise and comprehensive data handling practices.
    Similar Opportunities
    Centers of Excellence in Genomic Science (CEGS)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Centers of Excellence in Genomic Science (CEGS) program, aimed at fostering interdisciplinary research teams to tackle significant biomedical challenges from a genomics perspective. The initiative seeks to develop innovative concepts, methods, and technologies that can lead to transformative advancements in genomic science, genomic medicine, and computational genomics, with a focus on high-risk, high-reward projects that are unlikely to be pursued through standard funding mechanisms. With an estimated total program funding of $5 million and the expectation of awarding two grants, interested applicants can reach out to Stephanie A. Morris at morriss2@mail.nih.gov or call 301-435-5738 for further information. The application process is set to open with a synopsis posting on March 25, 2026, and will close on June 24, 2026, with awards anticipated by April 1, 2027.
    IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking applications for the Impact of Genomic Variation on Function (IGVF) Data and Coordinating Center (DACC) through a cooperative agreement. The DACC will serve as the central hub for the IGVF Consortium, tasked with developing a comprehensive data portal and cataloging variant impacts, while also facilitating consortium activities and collaborations within the broader research community. This initiative is crucial for enhancing the understanding of genomic variation and its implications in health. The estimated total program funding is $1,200,000, with one award anticipated, and the application process is expected to open in 2025, with a due date later that year. For further inquiries, interested applicants can contact Dr. Stephanie A. Morris at morriss2@mail.nih.gov or by phone at 301-435-5738.
    Genomic Community Resources (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-124) aimed at supporting the development of genomic community resources through cooperative agreements. This initiative seeks to enhance genomic research by funding projects that demonstrate broad applicability and significant value, focusing on the creation of genomic informatics tools, biological material collections, and community engagement efforts. The funded projects will play a crucial role in advancing both basic and clinical genomics research, with awards potentially lasting up to five years. Interested applicants, including a diverse range of organizations such as higher education institutions and nonprofits, must submit their applications by January 25, 2026, and can find further details and submission guidelines at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of the GREGoRi Technology Integration Center (TechIC) under the Genomics Research to Elucidate the Genetics of Rare Disease (GREGoR) program. This initiative aims to advance the diagnosis of rare genetic disorders by developing standards and best practices for new molecular methods, ultimately producing a multidimensional dataset to support the creation and evaluation of innovative diagnostic tools. The total estimated funding for this cooperative agreement is $3 million, with one award anticipated, and applications are expected to be due in 2026 following the publication of the Notice of Funding Opportunity (NOFO) in 2025. For further inquiries, interested applicants can contact Lisa H. Chadwick at lisa.chadwick@nih.gov or by phone at 301-435-7275.
    Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype," aimed at small businesses. This initiative seeks to support research that characterizes genomic variation and assesses the impact of individual variants on genome function through high-throughput methods, data collection on molecular and cellular phenotypes, and the development of robust data processing pipelines. The initiative is part of the Impact of Genomic Variation on Function (IGVF) Consortium, which will facilitate collaboration among funded centers to ensure resource accessibility and shared analysis strategies. The estimated total program funding is $3 million, with five awards expected, and the application process is anticipated to open in 2025, with a due date later that year. For further inquiries, interested applicants can contact Dr. Stephanie A. Morris at morriss2@mail.nih.gov or by phone at 301-435-5738.
    GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of the GREGoRi Data Coordination and Outreach Center, aimed at advancing the Genomics Research to Elucidate the Genetics of Rare Disease (GREGoR) program. This initiative seeks to enhance the diagnosis of rare genetic disorders by developing innovative tools and analytical methods to identify causal genes and variants, with the center serving as the primary coordination hub for data and resources generated by the GREGoRi program. The total estimated funding for this cooperative agreement is $2 million, with one award anticipated, and applications are expected to be due in 2026 following the publication of the Notice of Funding Opportunity (NOFO) in 2025. For further inquiries, interested applicants can contact Lisa H. Chadwick at lisa.chadwick@nih.gov or by phone at 301-435-7275.
    Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)" through a cooperative agreement. This initiative aims to solicit applications for research focused on developing, applying, and testing predictive models to analyze the effects of genomic variation on genome function, with funded centers becoming part of the Impact of Genomic Variation on Function (IGVF) Consortium. The total estimated program funding is $5 million, with approximately five awards expected, and the application process is anticipated to open in 2025, with a due date later that year. Interested applicants can reach out to Daniel Gilchrist, Ph.D., at daniel.gilchrist@nih.gov or by phone at 301-412-2926 for further information.
    GREGoRi Innovation Projects (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "GREGoRi Innovation Projects (U01 Clinical Trial Optional)" aimed at soliciting applications for research on proof of concept studies that explore innovative strategies for identifying genes or variants associated with rare genetic disorders. This initiative seeks to advance beyond traditional DNA sequencing methods by incorporating emerging molecular technologies, such as multi-omics and RNA-seq, to enhance the understanding of these disorders. The funding will be provided through a cooperative agreement, with no cost-sharing requirement, and is particularly targeted at small businesses engaged in health-related research. Interested applicants should prepare for the anticipated Notice of Funding Opportunity (NOFO) publication in 2025, with applications due in 2026, and can reach out to Lisa H. Chadwick at lisa.chadwick@nih.gov or by phone at 301-435-7275 for further information.
    Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the screening and functional validation of genomic variants associated with human congenital anomalies through the R01 Clinical Trial Not Allowed grant. This initiative aims to leverage advancements in genomic technologies to identify and validate genetic variants linked to congenital defects, intellectual developmental disabilities, and inborn errors of metabolism, thereby bridging the gap between genetic identification and functional impact on health. Eligible applicants include a wide range of institutions such as universities, nonprofits, and tribal governments, with a maximum budget of $499,999 per project year and a project duration of up to five years. Interested parties should submit their applications by January 7, 2028, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-185.html for further details.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)" aimed at supporting innovative research in computational genomics and data science. This initiative encourages applications that focus on developing novel analytical methodologies, tools, and software that can be broadly applied to enhance human health and disease understanding, with an emphasis on scalable systems for managing complex genomic data. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal colleges, with a maximum budget of $500,000 per year available for projects lasting up to five years. The application submission period opens on January 6, 2025, and closes on September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.